β-Thalassemia: Expert Insights on New Therapies for an Old Disease

Download All
Review this comprehensive program, including an on-demand Webcast and downloadable slidesets from a symposium at ASH 2019 and 3 expert commentaries, to gain expert perspectives on how to approach current therapeutic decisions for patients with β-thalassemia as well as on new data and promising agents that may soon change practice.
Maria Domenica Cappellini, MD
Janet L. Kwiatkowski, MD, MSCE
Sujit Sheth, MD

ClinicalThought

Are you up to date on the current optimal management of β-thalassemia?

Sujit Sheth, MD Released: October 15, 2019

Are you prepared to use the newly approved erythroid maturation agent luspatercept in the care of your adult patients with transfusion-dependent β-thalassemia?

Maria Domenica Cappellini, MD Released: January 13, 2020

Read expert answers to key audience questions from a recent symposium on optimal management of patients with β-thalassemia.

Janet L. Kwiatkowski, MD, MSCE Released: February 21, 2020
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings